Navigation Links
Results From IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients With Multiple Sclerosis
Date:9/21/2008

ts treated with the new formulation of Rebif(R) had zero combined unique active brain lesions at week 16, compared to only 16.7% in the placebo group.

Results for the secondary and tertiary endpoints of the IMPROVE study will be available at the end of the 40-week treatment period.

The safety profile of the new formulation of Rebif(R) reported in this study is consistent with the known safety profile of Rebif(R). No unexpected safety concerns were identified in this study.

The new formulation of Rebif(R) was approved in the European Union in August 2007 and in Canada in September 2007. It is now marketed in all EU countries and in Canada. The new formulation of Rebif(R) is not available in the United States.

About Rebif(R)

Rebif(R) (interferon beta-1a) is a disease-modifying drug used to treat relapsing forms of multiple sclerosis (MS) and is similar to the interferon beta protein produced by the human body. The efficacy of Rebif(R) in chronic progressive MS has not been established. Interferons are thought to help modulate the body's immune system and reduce inflammation. The exact mechanism is unknown.

Rebif(R), which was approved in Europe in 1998 and in the US in 2002, is registered in more than 80 countries worldwide. Rebif(R) has been proven to delay the progression of disability, reduce the frequency of relapses and reduce MRI lesion activity and area.* Rebif(R) is available in a 22 micrograms and 44 micrograms ready-to-use pre-filled syringe and a titration pack (8.8 micrograms).

Rebif(R) should be used with caution in patients with a history of depression, liver disease and seizures. Most commonly reported side effects are flu-like symptoms, injection site disorders, elevation of liver enzymes and blood cell abnormalities. Patients, especially those with depression, seizure disorders, or liver problems, should discuss treatment with Rebif(R) with their doctors. For more information about Rebif(R), please visi
'/>"/>

SOURCE Merck Serono
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Haemacure Reports Third Quarter 2007 Results
2. Brooke Franchise Corporation Announces Selected July Results
3. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
4. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
5. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
6. NBTY Announces Preliminary Unaudited Net Sales Results For August 2007
7. Martek Announces Third Quarter 2007 Financial Results
8. MDS Reports Third Quarter 2007 Results
9. Authentidate Holding Corp. to Report Fourth Quarter and Fiscal 2007 Year End Results on Thursday, September 13, 2007
10. Robbins & Myers to Release Fourth Quarter and 2007 Fiscal Year Results on Monday, October 15, 2007
11. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... The Florida Comprehensive Epilepsy and Seizure ... recognized by the National Association of Epilepsy Centers ... role of a specialized epilepsy center is to ... type and seizure syndrome, comprehensive epilepsy education for ... a patient’s diagnosis and surgical treatment or access ...
(Date:5/5/2015)... Beverly Hills Cosmetic Dentist, Arthur Glosman released a luxury ... sold at the offices of Arthur Glosman DDS, 450 N ... an online store . “I wanted to be one ... care and beauty with a luxurious collection of products designed ... , Dr. Glosman’s Advanced Dental Health + Beauty™ products ...
(Date:5/5/2015)... “Given that Hispanics are one in six people in the ... major step in the arsenal of facts documenting that we ... years, data have accumulated that the health of Hispanics did ... and the need to create new models of health and ... Jane L. Delgado, PhD, MS, President and CEO of the ...
(Date:5/5/2015)... 2015 Leveraging the industry-leading technology found ... an experienced team of fertility specialists are committed to ... around the globe. , “We’re honored that Maternity Health ... a global leader in reproductive medicine. The clinic offers ... in the world who play an important role in ...
(Date:5/5/2015)... 2015 The 2015 Crystal Ball, hosted by ... their global research, outreach and patient advocacy programs. The gala ... ceremony that attracted hundreds of supporters. , The 2015 gala ... the hepatitis B virus (HBV) by Dr. Baruch S. Blumberg, ... Prize in Medicine for his discovery of the virus in ...
Breaking Medicine News(10 mins):Health News:Florida Hospital Tampa Epilepsy Program Earns Designation as a Level 4 Epilepsy Center by the National Association of Epilepsy Centers (NAEC) 2Health News:Beverly Hills Dentist Arthur Glosman Launches New Dental Health And Beauty Product Line 2Health News:“Its about time,” Declares the National Alliance for Hispanic Health on First CDC Study of Hispanic Health 2Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 2Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 3Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 2Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 3
... , SACRAMENTO, Calif., Dec. 17 Just in time for ... tighten their firm grip on drunk drivers today by and declaring ... $8 million in grant funding to 148 law enforcement agencies for ... California Office of Traffic Safety (OTS) will fund more than 2,500 ...
... NEW YORK and ATLANTA, Dec. 17 The law firms of ... New York, announce that they have combined with the State of ... resolve a false claims act suit against Defendants Excellent Home Care ... Home Care. This case, along with United States ex ...
... ... reductions; more funding needed for continued success , ... Washington, DC (PRWEB) December 17, 2009 -- According to the ... than one third of affected countries included in the study have witnessed reduction in malaria ...
... , LOS ANGELES, Dec. 17 Pacific ... lip balms, today announced the launch of their new ... packs are specifically designed to reduce swelling and relieve ... applications. Researchers behind Thermal-Aid created a line of products, ...
... , , , COPENHAGEN, ... is, Copenhagen in the throes of an international conference on ... Clark Carr, president of the worldwide Narconon drug education ... climate change. But the streets thrum with student drums and ...
... ... at the Fisher Theatre on Dec. 17 for the Detroit-area,premiere of the award-winning musical “Jersey ... , , ... 2009 -- When the cast takes the stage at the Fisher Theatre on Dec. 17 ...
Cached Medicine News:Health News:California Announces 2010 as The Year of the Checkpoint 2Health News:California Announces 2010 as The Year of the Checkpoint 3Health News:$24 Million Settlement of New York State and Federal False Claims Act Case 2Health News:WHO World Malaria Report Shows Aid Efforts Are Working 2Health News:WHO World Malaria Report Shows Aid Efforts Are Working 3Health News:Thermal-Aid Bears Provide Warm Comfort to Children at Penny Lane for the Holidays 2Health News:Save the Planet. Stop Smoking Dope, Says Narconon 2Health News:Jersey Boys' Premiere Benefits Cancer Patients While Launching Beaumont Hospitals Fundraising Campaign 2Health News:Jersey Boys' Premiere Benefits Cancer Patients While Launching Beaumont Hospitals Fundraising Campaign 3
(Date:5/5/2015)... YORK , May 5, 2015  IBM Watson ... is collaborating with more than a dozen leading cancer ... and personalize treatment options for their patients. The institutes ... capabilities to reduce from weeks to minutes the ability ... and gather relevant information from medical literature to personalize ...
(Date:5/5/2015)... May 5, 2015  The preclinical contract research organization ... testing of drugs and safety testing of medical devices, ... of Preclinical Studies, presented at this week,s annual meeting ... (ARVO) in Denver, CO. The ... of a Novel, Cross-Linked, Bio-Absorbable Carboxymethyl Hyaluronic Acid (CMHA) ...
(Date:5/5/2015)...  American Laboratory Trading, Inc. (ALT), the leading provider ... veteran Anggie Becorest as their new Senior ... out of the company,s San Diego ... company,s west coast operations, diversifying the company,s offerings, and ... been the leader in the refurbished lab equipment market ...
Breaking Medicine Technology:Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 2Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 3Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 4Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 5Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 6Dr. Glen Gum of Absorption Systems Presents at The Association for Research in Vision and Ophthalmology (ARVO) Meeting 2Dr. Glen Gum of Absorption Systems Presents at The Association for Research in Vision and Ophthalmology (ARVO) Meeting 3ALT Names Anggie Becorest Senior Vice President of Business Development 2
... Oct. 12 Ethicon Endo-Surgery, Inc., today unveiled ... the 95th Annual Clinical Congress of the American ... of worldwide leading HARMONIC® ultrasonic and ENSEAL® advanced ... options that provide superior energy application for desired ...
... Leaders of the medical technology industry convene today ... Convention Center for the third annual AdvaMed 2009: ... medical technology executives, innovators, policymakers, media, and government ... states, are expected to attend this industry-designed conference. ...
Cached Medicine Technology:Ethicon Endo-Surgery Unveils Full Energy Portfolio for First Time at American College of Surgeons Clinical Congress 2Ethicon Endo-Surgery Unveils Full Energy Portfolio for First Time at American College of Surgeons Clinical Congress 3Medical Technology Executives Descend on D.C. as AdvaMed 2009: The MedTech Conference Kicks Off and Health Care Debate Continues 2Medical Technology Executives Descend on D.C. as AdvaMed 2009: The MedTech Conference Kicks Off and Health Care Debate Continues 3
...
...
Headlight module is mounted on UltraLite Plus headband or sweatband....
It is a magnifying headlight perfect for all applications and procedures where clear magnification and a natural white light increase accuracy and productivity....
Medicine Products: